Get started
Author

Кулинич Татьяна Михайловна

Observed names: Kulinich T.M., Kulinich, Tatiana, T M Kulinich, T. Kulinich, T. M. Kulinich, T.M. Kulinich, T.  M. Kulinich, TM Kulinich, Tatiana Kulinich, Tatiana M. Kulinich, Tatyana M. Kulinich, Tatyana Michailovna Kulinich, Tetyana Kulinich, Кулинич Т. М., Т М Кулинич, Т. М. Кулинич, Татьяна Михайловна Кулинич
ORCID: 0000-0003-2331-5753
Observed ORCID: 0000-0003-2331-5753
OpenAlex ID: A5090837905
Synthesis of modified conformationally fixed tricarbocyanine dyes for conjugation with therapeutic agents
2021 · Irina A. Doroshenko, Kamilla G. Aminulla, et al. · Mendeleev Communications · 15
New targeted anti CDK4/6 peptide MM-D37K.
2013 · Vladimir Konstantinovich Bozhenko, Tatyana Michailovna Kulinich, et al. · Journal of Clinical Oncology · 12
Comparison of Biological Effects of γ-Radiation of Low and Ultra-High Dose Rate on Lymphocytes and Cultured Human Malignant Lymphoma Cells
2019 · V. K. Bozhenko, A. V. Ivanov, et al. · Bulletin of Experimental Biology and Medicine · 8
Analysis of Cell Response to Ultrahigh Dose-Rate Proton Irradiation
2023 · S. V. Akulinichev, Yu. K. Gavrilov, et al. · Bulletin of the Russian Academy of Sciences Physics · 7
CAR T-cell therapy of solid tumors: promising approaches to modulating antitumor activity of CAR T cells
2019 · Ya.Yu. Kiseleva, A.M. Shishkin, et al. · Вестник Российского государственного медицинского университета · 5
PDF
Futures of CAR-T-therapy of solid tumors
2024 · I.A. Puchkov, T.M. Kulinich, et al. · Immunologiya · 4
PDF
Study of the suppression of a tumor growth expressing a carcinoembryonic antigen with a new high-tech drug carplasmin (CAR-T therapy) in Balb/c nude mice
2023 · V. K. Bozhenko, A. M. Shishkin, et al. · Advances in molecular oncology · 4
PDF
Analysis of the apoptotic effect of ultrahigh gamma dose rates on human peripheral blood lymphocytes in vitro
2017 · E.V. Grabovsky, G.M. Oleynik, et al. · Bulletin of Russian State Medical University · 4
PDF
Safety assessment and determination of a maximally tolerated dose of an RAS-GTPase inhibitor (iRAS) in the treatment of gastrointestinal tumors: preliminary results of the phase I trial
2024 · Vladimir K. Bozhenko, Sergey V. Goncharov, et al. · Almanac of Clinical Medicine · 3
PDF
Results from the First Biological Experiments on FLASH Therapy on the Accelerator at the Russian Academy of Sciences’ Institute for Nuclear Research
2020 · S. V. Akulinichev, V. K. Bozhenko, et al. · Bulletin of the Russian Academy of Sciences Physics · 3
Investigation of the expression level of genes-markers of proliferative activity in the mucosa at normal and various pathologies of the colon
2020 · T. M. Kulinich, M. V. Zakharenko, et al. · Advances in molecular oncology · 3
PDF
Therapeutic dose characteristics of the chimeric peptide of MM-D37K at parenteral introduction to the Balb/с nude mice with human colorectal carcinoma HCT-116
2017 · E. M. Uchanova, T. M. Kulinich, et al. · Russian Journal of Biotherapy · 3
PDF
Evaluation of CDK6 and p16/INK4a-Derived Peptides Interaction
2013 · Andrey Kazennov, Andrey Alekseenko, et al. · Computational Molecular Bioscience · 3
PDF
Optimization of CAR-T technology to improve the effectiveness of therapy for solid tumors
2025 · V.K. Bozhenko, Ya.Yu. Kiseleva, et al. · Immunologiya · 2
PDF
Optimization of IVT-mRNA nucleofection efficiency for non- activated peripheral blood lymphocytes
2025 · Ya.Yu. Kiseleva, K.G. Aminulla, et al. · Immunologiya · 2
PDF
Analysis of molecular phenotypes in normal mucosa and colorectal cancer in embryonic anatomical parts of the colon
2024 · Sergey V. Goncharov, Vladimir K. Bozhenko, et al. · Almanac of Clinical Medicine · 2
Исследование уровня двунитевых разрывов ДНК и механизмов клеточной гибели при воздействии на клетки рака легкого и меланомы фотонного излучения сверхвысокой мощности
2018 · Т. М. Кулинич, Е. Г. Крастелев, et al. · Вестник Российского государственного медицинского университета · 2
PDF
Cytostatic and cytotoxic properties of chimeric peptides containing cyclin-inhibiting fragments
2008 · T. M. Kulinich, V. P. Kharchenko, et al. · Bulletin of Experimental Biology and Medicine · 2
Results of a Phase IIa clinical trial of a RAS-GTPase inhibitor (Ing-Ras) for the treatment of gastrointestinal tumors
2025 · TM Kulinich, EA Kukoleva, et al. · Bulletin of Russian State Medical University · 1
PDF
Chemokines and its receptors in oncogenesis: a dual role in tumor progression and immune response
2025 · O.I. Goncharova, T.M. Kulinich, et al. · Immunologiya · 1
PDF
Changes in the concentration of freely circulating mutant DNA and wild-type DNA of the H3F3А (K27M) gene in the blood and cerebrospinal fluid of children with diffuse midline gliomas during a course of radiation therapy
2024 · O. S. Regentova, V. K. Bozhenko, et al. · South Russian Journal of Cancer · 1
PDF
Specific antitumor activity of anti-CA125 CAR-T lymphocytes against CA125-positive and CA125-negative cells
2024 · T. M. Kulinich, Ya. Yu. Kiseleva, et al. · Sechenov Medical Journal · 1
INVESTIGAISTION AND MODELING OF LEUKOCYTE RESPONSES IN THE BLOOD TO γ- IRRADIATION USING ENERGY PARAMETERS OF IMMUNE NETWORK CELLS
2024 · G. Morozova, M. Muny'os, et al. · Russian Journal of Biological Physics and Chemisrty · 1
Comparison of the Efficacy of Mrna and Plasmid Vectors in Transfection of Peripheral Blood Lymphocytes
2024 · Tatyana M. Kulinich, Yana Yu. Kiseleva, et al. · Russian Journal of Immunology · 1
Analysis of the expression of matrix RNA of a panel of genes of morphologically unchanged rectal epithelium as a method of early diagnosis of colon pathology
2023 · V.  C. Bozhenko, S. V. Goncharov, et al. · Advances in molecular oncology · 1
PDF
Works count: 94
Citation count: 95
H-index: 5
I10-index: 2
Year
Topic
Type